Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 20, 2018

SELL
$92.01 - $123.21 $20,242 - $27,106
-220 Closed
0 $0
Q4 2017

Jan 17, 2018

SELL
$89.56 - $98.21 $8,956 - $9,821
-100 Reduced 31.25%
220 $22,000
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $22,352 - $28,550
320
320 $28,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mu Investments Co., Ltd. Portfolio

Follow Mu Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mu Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mu Investments Co., Ltd. with notifications on news.